About Akpash Pharmaceuticals Private Limited
Data last updated:
Akpash Pharmaceuticals Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 April 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24233MP2004PTC016579. Its GSTIN is 23AAECA7936Q1Z6 (Madhya Pradesh).
The company has an authorised share capital of ₹24 Lakh and a paid-up capital of ₹20.74 Lakh. It is led by directors including Virendra Singh Mandloi and Ashish Joshi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 275 Secor – E Sanwer Road Industrial Area, Indore, Madhya Pradesh, India – 452015.
As per the financials filed for FY 2024, the company reported a revenue of ₹11.29 Lakh, a decline of 94% compared to the previous year. For the same year it recorded a net loss of ₹23.2 Lakh (net margin -205.4%) and EBITDA of -₹10.1 Lakh (EBITDA margin -89.4%). Revenue has declined at a compounded annual rate (CAGR) of 65% over three years and 53% over five years.
The company has about 6 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.95 Cr and satisfied charges of ₹80 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website akpashpharmaceuticals.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address275 Secor – E Sanwer Road Industrial Area, Indore, Madhya Pradesh, India – 452015
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Akpash Pharmaceuticals Private Limited FY 2024 filings available
Akpash Pharmaceuticals Private Limited reported revenue of ₹11.29 Lakh (down 94% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Akpash Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 53% over five years, including a 94% fall in the latest year. EBITDA fell 478% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Akpash Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹10.1 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹23.2 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Akpash Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -89.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -205.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Akpash Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Akpash Pharmaceuticals Private Limited
Akpash Pharmaceuticals Private Limited is audited by ANAND SAKLECHA & CO for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ANAND SAKLECHA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Akpash Pharmaceuticals Private Limited
Akpash Pharmaceuticals has 4 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Virendra Singh Mandloi Also directs: Emrays Biolife Sciences India LLP, Gurjar Infrastructure LLP, Namoaadi Realty LLP and 3 more | Director | 12 Jul 2018 | 8 Years 2 Months | Current |
| Ashish Joshi | Director | 19 Dec 2024 | 1 Years 9 Months | Current |
| Ajaj Ahmmad | Director | 19 Dec 2024 | 1 Years 9 Months | Current |
| Ravindra Mandloi Also directs: Emrays Biolife Sciences India LLP, Gurjar Infrastructure LLP, Namoaadi Realty LLP and 3 more | Director | 12 Jul 2018 | 8 Years 2 Months | Current |
Ownership and Shareholding of Akpash Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Akpash Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Jul 2017 | Others | ₹1.15 Cr | Open |
| 20 Nov 2009 | Allahabad Bank | ₹80 Lakh | Open |
| 18 Nov 2005 | State Bank of Indore | ₹15 Lakh | Satisfied |
| 28 Jan 2005 | Small Industries Development Bank of India | ₹65 Lakh | Satisfied |
Total charge records: 4 View all charges
Legal Cases of Akpash Pharmaceuticals Private Limited
Akpash Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed. Status as checked on 29 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (1 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Gwalior, Madhya Pradesh | Court case (RCT) | Filed against the company by Central Government | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Akpash Pharmaceuticals Private Limited
Akpash Pharmaceuticals Private Limited has a workforce of 6 employees as of Mar 23, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Akpash Pharmaceuticals Private Limited
Akpash Pharmaceuticals Private Limited has 11 board changes on record since 2012: 4 appointments and 7 cessations. The latest: Ajaj Ahmmad was appointed as Director on 19 Dec 2024.
11 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Akpash Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Akpash Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Akpash Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Akpash Pharmaceuticals Private Limited
Akpash Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAECA7936Q1Z6 | Madhya Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Akpash Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Akpash Pharmaceuticals Private Limited
Akpash Pharmaceuticals is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 April 2004 (22+ years old) and is registered under CIN U24233MP2004PTC016579.
Akpash Pharmaceuticals reported revenue of ₹11.29 Lakh for FY 2024 (down 94% YoY).
Akpash Pharmaceuticals has 4 current directors:
- Virendra Singh Mandloi - Director
- Ashish Joshi - Director
- Ajaj Ahmmad - Director
- Ravindra Mandloi - Director
Akpash Pharmaceuticals reported a net loss of ₹23.2 Lakh (net margin -205.4%) and EBITDA of -₹10.1 Lakh (EBITDA margin -89.4%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Akpash Pharmaceuticals is -65% over three years and -53% over five years. In the latest year (FY 2024) revenue fell 94%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Akpash Pharmaceuticals is 23AAECA7936Q1Z6, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Akpash Pharmaceuticals is U24233MP2004PTC016579. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Akpash Pharmaceuticals has 2 court cases on record: 2 filed against it.
Akpash Pharmaceuticals was incorporated on 27 April 2004, making it 22+ years old. It is registered with the Registrar of Companies, Gwalior.
Ajaj Ahmmad was appointed as Director on 19 Dec 2024. Ashish Joshi was appointed as Director on 19 Dec 2024. Pyar Singh Mandloi ceased to be Director on 24 Dec 2020. Akpash Pharmaceuticals has 11 board changes on record in total.